News Focus
News Focus
Post# of 257580
Next 10
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

Re: Biopharm investor post# 74280

Wednesday, 03/11/2009 10:10:43 PM

Wednesday, March 11, 2009 10:10:43 PM

Post# of 257580
H-W arithmetic on effective exclusivity period for NCE’s:
 
4.0 yrs to earliest generic application (statutory NCE period less 1 yr)
+ 2.5 yrs (automatic stay on final FDA approval)
=========
6.5 yrs

+0.5 yrs if pediatric extension applies
=========
7.0 yrs total effective period of exclusivity

In other words, BIO and GPhA are still far apart, but not as far apart as the news reports make it seem.

p.s. I know you know all this, but some readers may not.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today